Table 3 Relationship between vitamin D status and both frequency and severity of exacerbations in the last year in CF bronchiectasis patients
From: Impact of vitamin D status on CF and non-CF bronchiectasis outcomes
Pulmonary exacerbations in the last year | Vitamin D group | P-value | Post hoc | |||
|---|---|---|---|---|---|---|
Deficient (< 20 ng/mL) | Insufficient (20–29 ng/mL) | Sufficient (≥30 ng/mL) | ||||
Frequency | Infrequent (< 3 times) | 5(33.3%) | 4(100.0%) | 1(100.0%) | 0.033# | (I vs II) *, (I vs III) * |
Frequent (≥3 times) | 10(66.7%) | 0(0.0%) | 0(0.0%) | |||
Severity | Mild | 1(6.7%) | 4(100.0%) | 1(100.0%) | <0.001# | (I vs II) *, (I vs III) * |
Moderate | 7(46.7%) | 0(0.0%) | 0(0.0%) | |||
Severe | 7(46.7%) | 0(0.0%) | 0(0.0%) | |||